• In the media
  • Biosimilar Access: Is The Industry Overlookin...
Media - published on 11 Sep 2018

Biosimilar Access: Is The Industry Overlooking Critical Markets?

Anna Rose Welch interviews Jayasree K. Iyer and writes about biosimilar development and the work of the Foundation on assessing pharmaceutical company action to improve access to cancer care in low- and middle-income countries.

Learn more

View our detailed overview of each company’s performance in the Index, including breakdowns of their product portfolios and R&D pipelines.

Back to top |